Idorsia (CHIX:IDIAZ) Other Net Income (Loss) : CHF0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Other Net Income (Loss)?

Idorsia's Other Net Income (Loss) for the three months ended in Mar. 2025 was CHF0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was CHF0.0 Mil.

Idorsia's quarterly Other Net Income (Loss) increased from Sep. 2024 (CHF0.0 Mil) to Dec. 2024 (CHF0.0 Mil) and increased from Dec. 2024 (CHF0.0 Mil) to Mar. 2025 (CHF0.0 Mil).

Idorsia's annual Other Net Income (Loss) declined from Dec. 2022 (CHF0.0 Mil) to Dec. 2023 (CHF0.0 Mil) but then stayed the same from Dec. 2023 (CHF0.0 Mil) to Dec. 2024 (CHF0.0 Mil).

Idorsia Other Net Income (Loss) Historical Data

The historical data trend for Idorsia's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Other Net Income (Loss) Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Idorsia Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Idorsia Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.0 Mil.

Idorsia Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Idorsia's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (CHIX:IDIAz) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

IDRSF:USA 0RQE:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia Headlines

No Headlines